Skip to main content
Log in

Short-term kinetics of serum adrenal steroids and plasma ACTH after a single dose of metyrapone in man

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The in vivo influence of metyrapone (M) on different adrenal enzymes has been studied by simultaneous measurement of serum progesterone (P), 17-hydroxyprogesterone (17-OHP), deoxycorticosterone (DOC), corticosterone (B), deoxycortisol (S), 18-hydroxydeoxycorticosterone (18-OHDOC), aldosterone and cortisol (F) as well as by the measurement of plasma ACTH before and after oral administration of 40 mg of M/kg at 08:15 in four healthy male subjects. The well known inhibitory effect of M on adrenal 11-hydroxylase is demonstrated by a decrease of serum F and B and a synchronous increase of serum S and DOC after administration of M. The additional inhibition of 18-hydroxylase by M is documented by a decrease of serum 18-OHDOC in spite of a marked increase of serum DOC after M. The moderate increase of serum P and 17-OHP soon after drug administration, although plasma ACTH is highly elevated at this time, as well as the marked increase of these steroids in the afternoon synchronously to a rise of serum F and B suggest a further inhibitory effect of M on an enzyme prior to the total corticosteroid biosynthesis. This effect of M should be taken into account if ACTH activity is monitored in terms of adrenal steroid output in the metyrapone test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Liddle G.W., Island D., Lance E.M., Harris A.P. Alterations of adrenal steroid patterns in man resulting from treatment with a chemical inhibitor of 11-β-hydroxylation. J. Clin. Endocrinol. Metab. 18: 906, 1958.

    Article  PubMed  CAS  Google Scholar 

  2. Liddle G.W., Estep H.L., Kendall J.W., Williams W.C., Townes A.W. Clinical application of a new test of pituitary reserve. J. Clin. Endocrinol. Metab. 19: 875, 1959.

    Article  PubMed  CAS  Google Scholar 

  3. Child D.F., Burke C.W., Burley D.M., Rees L.H., Fraser T.R. Drug control of Cushing’s syndrome. Combined aminoglutethimide and metyrapone therapy. Acta Endocrinol. (Kbh.) 82: 330, 1976.

    CAS  Google Scholar 

  4. Jeffcoate W.J., Rees L.H., Tomlin S., Jones A.E., Edwards C.R., Besser G.M. Metyrapone in long-term management of Cushing’s disease. Brit. Med. J. 2: 215, 1977.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  5. Doe R.P., Gold E.M. The metyrapone test of pituitary function. Postgrad. Med. 46: 157, 1969.

    PubMed  CAS  Google Scholar 

  6. Carballeira A., Fishman L.M., Jacobi J.D. Dual sites of inhibition by metyrapone of human adrenal steroidogenesis: correlation of in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 42: 687, 1976.

    Article  PubMed  CAS  Google Scholar 

  7. Carballeira A., Cheng S.C., Fishman L.M. Site of metyrapone inhibition of steroid biosynthesis by rat adrenal mitochondria. Acta Endocrinol. (Kbh.) 76: 703, 1974.

    CAS  Google Scholar 

  8. Cheng S.C., Harding B.W., Carballeira A. Effect of metyrapone on pregnenolone biosynthesis and on cholesterol cytochrome P-450 interaction in the adrenal. Endocrinology 94: 1451, 1974.

    Article  PubMed  CAS  Google Scholar 

  9. Erickson R.E., Ertel R.J., Ungar F. Effect of SU-4885 on steroid 18-hydroxylation in the mouse adrenal in vitro. Endocrinology 78: 343, 1966.

    Article  PubMed  CAS  Google Scholar 

  10. Kraulis I., Birmingham M.K. Inhibition of the biosynthesis of 18-hydroxy-11-deoxycorticosterone by SU-4885. Can. J. Biochem. 43: 1471, 1965.

    Article  PubMed  CAS  Google Scholar 

  11. De Nicola A.F., Dahl V. Acute effects of SU-4885 and its reduced derivative (SU-5236) on the adrenocortical secretion in the rat. Endocrinology 89: 1236, 1971.

    Article  PubMed  Google Scholar 

  12. Traikov H., De Nicola A.F., Birmingham M.K. Effects of 2 methyl-1, 2-bis, (3’-pyridyl)-1-propanol (reduced metopirone) on the formation of 18-hydroxylated steroids by quartered rat adrenals. Steroids 13: 457, 1969.

    Article  PubMed  CAS  Google Scholar 

  13. Schneider P.B. Falsely abnormal responses of normal subjects to the metopirone (SU-4885) test for pituitary ACTH reserve. J. Clin. Endocrinol. Metab. 24: 218, 1964.

    Article  PubMed  CAS  Google Scholar 

  14. Schöneshöfer M. Simultaneous determination of eight adrenal steroids in human serum by radioimmunoassay. J. Steroid Biochem. 8: 995, 1977.

    Article  PubMed  Google Scholar 

  15. Voigt K.H., Fehm H.L., Pfeiffer E.F. Radioimmunoassay of adrenocorticotropic hormone (ACTH) in plasma. In: Breuer H., Hamel D., Kruskemper H.L. (Eds.), Methods of hormone analysis. Thieme-Verlag, Stuttgart, 1976, p. 12.

    Google Scholar 

  16. Schöneshöfer M. Computer program for evaluation, physico-chemical characterization and optimization of competitive protein binding assays: comparison of four curve-fitting models in peptide and steroid radioimmunoassays. Clin. Chim. Acta 77: 101, 1977.

    Article  PubMed  Google Scholar 

  17. Hildebrandt A.G. The binding of metyrapone to cytochrome P-450 and its inhibitory action on microsomal hepatic mixed function oxidation reactions. Biochem. Soc. Symp. 34: 79, 1972.

    PubMed  CAS  Google Scholar 

  18. Simon S., Kahl G.G., Netter K.J. Beeinflussung von Redoxstatus und Sauerstoffverbrauch isoliert perfundierter Rattenlebern durch Metyrapon. Naunyn Schmiedebergs Arch. Pharmacol. 226: 454, 1970.

    Google Scholar 

  19. Bruno O.D., Leclerq R., Virasoro E., Copinschi G. Extraadrenal actions of metyrapone in man: Effects on plasma cortisol disappearance, growth hormone secretion and glucose metabolism. J. Clin. Endocrinol. Metab. 32: 260, 1971.

    Article  PubMed  CAS  Google Scholar 

  20. Takahara J., Ogawa N., Ofuji T. Etraadrenal action of metyrapone upon human growth hormone secretion in man. Endocrinol. Jpn. 19: 197, 1972.

    Article  PubMed  CAS  Google Scholar 

  21. Levin J., Zumoff P., Fukushima D.K. Extraadrenal effects of metyrapone in man. J. Clin. Endocrinol. Metab. 47: 845, 1978.

    Article  PubMed  CAS  Google Scholar 

  22. Blichert-Toft M., Folke K., Nielsen M.L. Effect of metyrapone and corticotrophin infusion on cortisol disappearance rate in man. J. Clin. Endocrinol. Metab. 35: 59, 1972.

    Article  PubMed  CAS  Google Scholar 

  23. Hellmann, L., Nakada F., Curti J., Weitzman E.D., Kream J., Roffwarg H., Ellman S., Fukushima D.K., Gallagher T.F. Cortisol is secreted episodically by normal man. J. Clin. Endocrinol. Metab. 30: 411, 1970.

    Article  Google Scholar 

  24. Berson S.A., Yalow R.S. Radioimmunoassay of ACTH in plasma. J. Clin. Invest. 47: 2725, 1968.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  25. Voigt K.H., Fehm H.L., Reck R., Pfeiffer E.F. Spontaneous and stimulated secretion of QUSO-extractable immunoassayable ACTH in man. Klin. Wochenschr. 52: 516, 1974.

    Article  PubMed  CAS  Google Scholar 

  26. Schöneshöfer M., L’age M. Oelkers W. Short time kinetics of deoxycorticosterone, deoxycortisol, corticosterone and cortisol during single dose metyrapone test. Acta Endocrinol. (Kbh.) 85: 109, 1977.

    Google Scholar 

  27. Sawano S., Saito T., Shizume K., Takebe K. Simultaneous determinations of plasma ACTH and GH levels after an oral metyrapone dose. Endocrinol. Jpn. 19: 477, 1972.

    Article  PubMed  CAS  Google Scholar 

  28. Meikle A.W., West S.C., Weed J.A., Tyler F.H. Single-dose metyrapone test. 11-β-hydroxylase inhibition by metyrapone and reduced metyrapone assayed by radioimmunoassay. Nature 253: 290, 1975.

    Article  Google Scholar 

  29. Williamson D.G., O’Donnel V.J. Mechanism of metopirone inhibition of a soluble adrenal steroid 11-beta-hydroxylase. Can. J. Biochem. 45: 153, 1967.

    Article  PubMed  CAS  Google Scholar 

  30. Williamson D.G., O’Donnel V.J. The interaction of metopirone with adrenal mitochondrial cytochrome P-450. A mechanism for the inhibition of adrenal steroid 11-beta-hydroxylation. Biochemistry 8: 1306, 1969.

    Article  PubMed  CAS  Google Scholar 

  31. Dale S.L., Komanicky P., Pratt J.H., Melby J.C. Radioimmunoassay of 18-hydroxy-11-deoxycorticosterone in plasma. J. Endocrinol. Metab. 43: 803, 1976.

    Article  CAS  Google Scholar 

  32. Björkhem I., Karlmar K.E. Common characteristics of the cytochrome P-450 system involved in 18- and 11-β-hydroxylation of deoxycorticosterone in rat adrenals. J. Lipid. Res. 18: 592, 1977.

    PubMed  Google Scholar 

  33. Watanuki M., Riley B.E., Hall P.F. Cytochrome P-450 for 11-β- and 18-hydroxylase activities of bovine adrenocortical mitochondria: one enzyme or two? Biochemistry 17: 127, 1978.

    Article  PubMed  CAS  Google Scholar 

  34. Jenkins J.S., Meakin J.W., Nelson D.H. A comparison of the inhibitory effects of 2-methyl-1,2-bis (3-pyridyl)-1 -propanone and amphenone B on adrenal cortical secretion in the dog. Endocrinology 64: 572, 1959.

    Article  PubMed  CAS  Google Scholar 

  35. Meikle A.W., Jubiz W., Hutchings M.P., West C.D., Tyler F.H. A simplified metyrapone test with determination of plasma 11-deoxycortisol (metyrapone test with plasma S). J. Clin. Endocrinol. Metab. 29: 985, 1969.

    Article  PubMed  CAS  Google Scholar 

  36. Leisti S. Evaluation of 3 hour metyrapone test in children and adolescents. Clin. Endocrinol. (Oxf). 6: 305, 1977.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The paper includes parts of the thesis of B. Schefzig and was in part presented to the 23rd Symposium of the Deutsche Gesellschaft für Endokrinologie, Ulm 1978, the abstracts of which are published in Acta Endocrinologica (Kopenhagen), (Suppl.) 215, 1978.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schöneshöfer, M., Schefzig, B. & Arabin, S. Short-term kinetics of serum adrenal steroids and plasma ACTH after a single dose of metyrapone in man. J Endocrinol Invest 3, 229–236 (1980). https://doi.org/10.1007/BF03348268

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348268

Key-words

Navigation